Genesen

OverviewSuggest Edit

Genesen (주식회사 젠센) is a company that develops drugs for the treatment of autoimmune and inflammatory diseases. It offers peptide-based drugs that selectively inhibit toll-like receptors(TLRs).

TypePrivate
Founded2018
Websitegenesenbio.com

Latest Updates

Employees (est.) (Jun 2020)7

Genesen Financials and Metrics

Summary Metrics

Founding Date

2018

Genesen total Funding

$1.9 m

Genesen latest funding size

$1.90 m

Time since last funding

5 months ago
Genesen's latest funding round in January 2020 was reported to be $1.9 m. In total, Genesen has raised $1.9 m
Show all financial metrics

Genesen Online and Social Media Presence

Embed Graph

Genesen Frequently Asked Questions

  • When was Genesen founded?

    Genesen was founded in 2018.

  • How many employees does Genesen have?

    Genesen has 7 employees.

  • Who are Genesen competitors?

    Competitors of Genesen include Vertex Pharmaceuticals, Alimera Sciences and Marinus Pharmaceuticals.